Found: 45
Select item for more details and to access through your institution.
Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
- Published in:
- Journal of Gene Medicine, 2005, v. 7, n. 5, p. 584, doi. 10.1002/jgm.703
- By:
- Publication type:
- Article
Sequential or combined designs for Phase I/II clinical trials? A simulation study.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 635, doi. 10.1177/1740774519872702
- By:
- Publication type:
- Article
Bone Sarcomas: From Biology to Targeted Therapies.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Bone Sarcomas: From Biology to Targeted Therapies.
- Published in:
- Sarcoma, 2012, p. 1, doi. 10.1155/2012/301975
- By:
- Publication type:
- Article
Proteomic Analysis of Neuroblastoma-Derived Exosomes: New Insights into a Metastatic Signature.
- Published in:
- Proteomics, 2017, v. 17, n. 23/24., p. n/a, doi. 10.1002/pmic.201600430
- By:
- Publication type:
- Article
Outcome of children and adolescents with central nervous system tumors in phase I trials.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 137, n. 1, p. 83, doi. 10.1007/s11060-017-2698-z
- By:
- Publication type:
- Article
A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 113, n. 1, p. 127, doi. 10.1007/s11060-013-1098-2
- By:
- Publication type:
- Article
Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00445-1
- By:
- Publication type:
- Article
Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors.
- Published in:
- International Journal of Oncology, 2017, v. 50, n. 1, p. 203, doi. 10.3892/ijo.2016.3792
- By:
- Publication type:
- Article
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells.
- Published in:
- EMBO Molecular Medicine, 2024, v. 16, n. 8, p. 1840, doi. 10.1038/s44321-024-00097-z
- By:
- Publication type:
- Article
Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients.
- Published in:
- Pediatric Nephrology, 1996, v. 10, n. 5, p. 625, doi. 10.1007/s004670050175
- By:
- Publication type:
- Article
Precision cancer medicine: Concepts, current practice, and future developments.
- Published in:
- Journal of Internal Medicine, 2023, v. 294, n. 4, p. 455, doi. 10.1111/joim.13709
- By:
- Publication type:
- Article
Establishment and characterization of <italic>in vivo</italic> orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 3, p. 665, doi. 10.1002/cam4.1346
- By:
- Publication type:
- Article
Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1166063
- By:
- Publication type:
- Article
Mesenchymal Transition and PDGFRA Amplification/ Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0030313
- By:
- Publication type:
- Article
Patient‐derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 5, p. 985, doi. 10.1111/bjh.18953
- By:
- Publication type:
- Article
Precision medicine at its best: Prolonged survival in a child presenting a secondary mesothelioma treated with crizotinib.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 2, p. 1, doi. 10.1002/pbc.28666
- By:
- Publication type:
- Article
Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevacizumab.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- case study
Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Vemurafenib in pediatric patients with BRAFV 600E mutated high-grade gliomas.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 6, p. 1101, doi. 10.1002/pbc.24891
- By:
- Publication type:
- Article
Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 16, p. 2448, doi. 10.1002/cncr.28728
- By:
- Publication type:
- Article
Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01827-6
- By:
- Publication type:
- Article
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01827-6
- By:
- Publication type:
- Article
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01827-6
- By:
- Publication type:
- Article
A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01271
- By:
- Publication type:
- Article
Do medulloblastoma tumors meet the food and drug administration criteria for anti-erbB2 therapy with trastuzumab?
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, n. 1, p. 163, doi. 10.1002/pbc.20908
- By:
- Publication type:
- Article
p53 pathway dysfunction in primary childhood ependymomas.
- Published in:
- Pediatric Blood & Cancer, 2006, v. 46, n. 5, p. 604, doi. 10.1002/pbc.20532
- By:
- Publication type:
- Article
Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of-heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1265469
- By:
- Publication type:
- Article
Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3532, doi. 10.3390/cancers15133532
- By:
- Publication type:
- Article
In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 997, doi. 10.3390/cancers11070997
- By:
- Publication type:
- Article
Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma.
- Published in:
- 2015
- By:
- Publication type:
- Report
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 6, p. 997, doi. 10.1093/neuonc/noab274
- By:
- Publication type:
- Article
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1542, doi. 10.1093/neuonc/nox109
- By:
- Publication type:
- Article
Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 7, p. 953, doi. 10.1093/neuonc/nou330
- By:
- Publication type:
- Article
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 9, p. 1236
- By:
- Publication type:
- Article
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 1, p. 109
- By:
- Publication type:
- Article
The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts.
- Published in:
- International Journal of Cancer, 2011, v. 128, n. 11, p. 2748, doi. 10.1002/ijc.25611
- By:
- Publication type:
- Article
EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 1, p. 209, doi. 10.1002/ijc.23488
- By:
- Publication type:
- Article
Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0142612
- By:
- Publication type:
- Article
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 3, p. 283, doi. 10.1007/s11523-022-00888-9
- By:
- Publication type:
- Article
Metabolic activity and clinical features of primary ganglioneuromas.
- Published in:
- 2001
- By:
- Publication type:
- journal article